{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:03:45Z","timestamp":1784271825915,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jdcr.2026.04.054","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:15:52Z","timestamp":1777965352000},"page":"25-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prompt recurrence of granuloma annulare upon Janus kinase inhibitor discontinuation"],"prefix":"10.1016","volume":"73","author":[{"given":"Arman","family":"Haveric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Markeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2026.04.054_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40257-021-00636-1","article-title":"Granuloma annulare: an updated review of epidemiology, pathogenesis, and treatment options","volume":"23","author":"Joshi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdcr.2026.04.054_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2019.12.028","article-title":"Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways","volume":"83","author":"Min","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2026.04.054_bib3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaci.2020.10.012","article-title":"Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.04.054_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00403-025-04248-1","article-title":"Systemic Janus kinase inhibitors in the management of granuloma annulare","volume":"317","author":"Stratman","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"10.1016\/j.jdcr.2026.04.054_bib5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/ijd.17684","article-title":"Emerging role of Janus kinase inhibitors in treating granuloma annulare: a clinical, narrative review of efficacy and safety","volume":"64","author":"Heidari","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2026.04.054_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1698816","article-title":"Clinical updates of JAK inhibitors in cutaneous granulomatous diseases","volume":"16","author":"Gu","year":"2025","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jdcr.2026.04.054_bib7","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1111\/jdv.19073","article-title":"JAK1\/2 pathway\u2013specific treatment of disseminated granuloma annulare with baricitinib","volume":"37","author":"Jadoul","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.04.054_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ced\/llac110","article-title":"Rapid improvement of refractory generalized granuloma annulare with the Janus kinase inhibitor baricitinib in two patients","volume":"48","author":"Kim","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdcr.2026.04.054_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.25259\/IJDVL_215_2024","article-title":"Therapeutic success of tofacitinib in granuloma annulare: a retrospective case series of 15 patients","volume":"91","author":"Dev","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626002559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:15:48Z","timestamp":1784268948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626002559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":9,"alternative-id":["S2352512626002559"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.054","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prompt recurrence of granuloma annulare upon Janus kinase inhibitor discontinuation","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.04.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}